SAMRAT PHARMACHEM
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Samrat Pharmachem along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.17₹ -0.55
As on Sep 16, 2025, 4:01 PM IST
Samrat Pharmachem Price Performance
Today's LowToday's High
₹322.40₹327.95
₹322.40
52 Weeks' Low52 Weeks' High
₹302.05₹646.00
₹322.40
Open Price
₹322.95
Prev. Close
₹322.95
Volume
531
Over the last 5 years, the share price of Samrat Pharmachem has gained 23.26% CAGR. Over the past year, the corresponding return has been -49.01%.
Samrat Pharmachem’s current P/E of 20.68x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Samrat Pharmachem Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Samrat Pharmachem | 1.35 | -0.28 | -5.76 | 0.61 | -49.4 | -34.62 | 23.26 |
| Sun Pharmaceutical Industries | 1.08 | -1.32 | -2.3 | -5.58 | -13.67 | 22.86 | 25.44 |
| Divi's Laboratories | 0.84 | -1.39 | -6.98 | 7.26 | 11.48 | 19.38 | 13.39 |
| Cipla | -0.48 | -0.53 | 3.5 | 4.23 | -6.88 | 14.18 | 15.63 |
| Torrent Pharmaceuticals | -1.63 | -3.25 | 8.69 | 15.5 | 2.4 | 33.75 | 19.96 |
| Dr. Reddy's Laboratories | 0.49 | 3.7 | -0.64 | 13.92 | -1.18 | 17.09 | 7.19 |
| Mankind Pharma | -1.56 | 3.97 | 9.17 | 18.23 | 4.67 | 21.72 | 12.52 |
| Zydus Lifesciences | -0.55 | 4.77 | 7.79 | 15.71 | -6.91 | 42.05 | 21.62 |
| Lupin | 3.72 | 4.15 | 5.54 | 3.02 | -9.66 | 48.04 | 14.81 |
| Abbott India | -0.88 | -4.93 | -2.46 | 2.81 | 7.44 | 20.9 | 13.41 |
| Alkem Laboratories | 3.56 | 3.02 | 14.49 | 14.4 | -11.41 | 20.01 | 14.29 |
| Aurobindo Pharma | 3.96 | 0.18 | -1.58 | -1.88 | -29.64 | 26.95 | 5.6 |
| Glenmark Pharmaceuticals | -2.57 | 5.17 | 25.57 | 45.12 | 21.2 | 77.31 | 32.95 |
| Laurus Labs | -0.17 | 3.44 | 35.51 | 53.95 | 78.57 | 20.1 | 27.14 |
| Biocon | -1.06 | -1.13 | 2.14 | 7.85 | -4.1 | 7.35 | -3.86 |
| Anthem Biosciences | 1.87 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
| GlaxoSmithKline Pharmaceuticals | -3.13 | -1.6 | -15.6 | 1.95 | -1.96 | 24.23 | 9.16 |
| Cohance Lifesciences | -0.02 | 10.08 | -0.3 | -12.87 | -14.37 | 28.96 | 21.52 |
| Gland Pharma | 6.2 | 2.52 | 15.71 | 30.13 | 9.43 | -4.11 | 2.12 |
| Ipca Laboratories | -0.22 | -5.32 | -3.38 | -0.34 | -9.99 | 14.97 | 3.52 |
Over the last one year, Samrat Pharmachem has declined 49.40% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Samrat Pharmachem has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Samrat Pharmachem Financials
Samrat Pharmachem Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 319.79 | 322.55 |
| 10 | 320.12 | 321.86 |
| 20 | 321.31 | 324.29 |
| 50 | 342.95 | 334.93 |
| 100 | 353.18 | 345.66 |
| 200 | 359.36 | 361.46 |
Samrat Pharmachem Share Holding Pattern
In the latest quarter, Samrat Pharmachem remained same as its previous close in promoter holding, while DII stake increased to 3.24%, FII holding fell to 0.00%, and public shareholding unchanged at 47.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Samrat Pharmachem Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 04, 2025, 7:28 PM IST | Samrat Pharma - Reg. 34 (1) Annual Report. |
| Sep 04, 2025, 7:20 PM IST | Samrat Pharma - Book Closure: Friday, September 19, 2025 To Thursday, September 25, 2025 (Both Days Inclusive) |
| Sep 04, 2025, 7:16 PM IST | Samrat Pharma - Record Date - Thursday, September 18, 2025 |
| Sep 04, 2025, 7:09 PM IST | Samrat Pharma - Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday, September 25, 2025 |
| Aug 14, 2025, 2:42 AM IST | Samrat Pharma - Un-Audited Financial Results For The Quarter Ended June 30, 2025 |
About Samrat Pharmachem
Samrat Pharmachem Ltd. is a Public Limited Listed company incorporated on 16/06/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1992PLC017820 and registration number is 017820. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 285.86 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No A2/3445, GIDC, Phase IV, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Lalit MehtaChairman & Managing Director
- Mr. Rajesh MehtaExecutive Director & CFO
- Mr. Megh MehtaExecutive Director
- Mr. Mahendra PipaliaInd. Non-Executive Director
- Mr. Samir KotharyInd. Non-Executive Director
- Ms. Renu DharodInd. Non-Executive Director
FAQs on Samrat Pharmachem Share Price
What is the share price of Samrat Pharmachem?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Samrat Pharmachem is ₹322.40 as on Sep 16, 2025.
What kind of stock is Samrat Pharmachem?
The Samrat Pharmachem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Samrat Pharmachem?
The market cap of Samrat Pharmachem is ₹99.61 Cr as on Sep 16, 2025.
What are today's High and Low prices of Samrat Pharmachem?
Today’s highest and lowest price of Samrat Pharmachem are ₹327.95 and ₹322.40.
What are the 52 Week High and 52 Week Low of Samrat Pharmachem?
The 52-week high/low is the highest and lowest price at which Samrat Pharmachem stock has traded in the past 52-week or nearly a year. The 52-week high of Samrat Pharmachem is ₹646.00 and 52-week low of Samrat Pharmachem is ₹302.05 as on Sep 16, 2025.
How has the Samrat Pharmachem performed historically in terms of returns?
The Samrat Pharmachem has shown returns of -0.17% over the past day, -0.28% for the past month, -7.41% over 3 months, -49.01% over 1 year, -34.62% across 3 years, and 23.26% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Samrat Pharmachem?
P/E ratio of and PB ratio of Samrat Pharmachem are 20.68 and 1.39 on Sep 16, 2025. While the company gives a dividend yield of 0.31 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data